EQS-Adhoc: LifeWatch AG: LOI with GE Healthcare to develop strategic relationship signed

EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Letter of Intent LifeWatch AG: LOI with GE Healthcare to develop strategic relationship signed

2016-10-24 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR.

*LifeWatch signs LOI with GE Healthcare to develop strategic relationship*

Zug/Switzerland, October 24, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market, announces that the company has signed a Letter of Intent (LOI) with GE Medical Systems Information Technologies, Inc., a Wisconsin corporation doing business as GE Healthcare, along with its affiliates (GE Healthcare).

The purpose of the LOI is to explore the opportunities of a long-term strategic relationship regarding the exclusive third-party distribution of LifeWatch's monitoring services in the USA and possible other markets as well as other potential ventures. This LOI is non-binding and the intended relationship is subject to the signing of a definitive cooperation agreement.

*For further questions: * LifeWatch AG, Andrew Moore, CFO c/o Dynamics Group, Doris Rudischhauser Phone +41 43 268 27 40 / Mobile +41 79 410 81 88 E-Mail: investor-relations@lifewatch.com

*About LifeWatch AG*

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products. For additional information, please visit www.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at http://www.irlifewatch.com/websites/lifewatch_ir/English/9510/alert-service.ht ml [1]

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, the business strategy, and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.

Additional features:

Document: http://n.eqs.com/c/fncls.ssp?u=VCJULDUWEP [2] Document title: LifeWatch signs LOI with GE Healthcare to develop strategic relationship

End of ad hoc announcement Language: English Company: LifeWatch AG Baarerstrasse 139 6300 Zug Switzerland Phone: +41 41 728 67 78 Internet: www.lifewatch.com ISIN: CH0012815459 Valor: 811189 Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open Market in Frankfurt ; SIX Swiss Exchange

End of News EQS Group News Service 513725 2016-10-24

1: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=b45dffe43f3085d39768825443912bf6&application_id=513725&site_id=vwd&application_name=news 2: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=4ae9788ebeb860150fe716e5bbe626ad&application_id=513725&site_id=vwd&application_name=news (END) Dow Jones Newswires

   October 24, 2016 01:00 ET (05:00 GMT)- - 01 00 AM EDT 10-24-16